Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Host gene that makes people vulnerable to leprosy discovered

10.02.2003


An international research team, led by Dr. Erwin Schurr and Dr. Thomas Hudson, Scientists at the Research Institute of the McGill University Health Centre, have identified a gene on human chromosome 6 that makes people vulnerable to leprosy. The study will be published in the March 2003 issue of Nature Genetics.



"This discovery will now allow us to study how the gene works and how it influences the infectious process. This is an important step toward the development of innovative prevention and treatment strategies for leprosy", stated Dr. Schurr.

"Leprosy has plagued humans for many centuries and it continues to be a concern in many countries," stated Dr. Marcel Behr, Infectious Disease Specialist at the MUHC and Assistant Professor of Medicine at McGill University. "These studies lead the way to developing better treatment and a possible vaccine."


Leprosy, a chronic disease caused by infection with the bacteria Mycobacterium leprae, affects approximately one million people worldwide. While it is a rare disease in Canada and the United States, the World Health Organization has identified 91 countries in which leprosy infection is highly prevalent. Symptoms of leprosy include pigmented skin lesions, permanent nerve damage leading to numbness of the feet and hands and, if left untreated, the disease may result in gross disfiguration including loss of finger, toes, feet and hands. The leprosy bacteria are transmitted through direct personal contact or contaminated respiratory droplets.

Schurr and his colleagues used a technique called "genome scanning" to map the gene. The research team analyzed DNA samples from nearly 100 families who were susceptible to the disease, and found that the families shared a common gene variant on chromosome 6. They then analyzed the DNA of an additional 200 families with leprosy to confirm their findings. "In the last few years advances in technology have made complex genetic analyses, such as those used in this study, possible, "stated Dr. Thomas Hudson. "Without these advances and the cooperation of the families, this research would not have been possible."

This is the second study, published in 2003 by McGill/CGDN scientists, that illustrates the importance of host genes in infectious disease. Dr. Philippe Gros discovered a gene (Naip-5) could make mice resistant to Legionnaire’s Disease. "We are now looking forward to applying the same gene identification strategies for other common infectious diseases such as tuberculosis and malaria", stated Dr. Alexandre Alcaïs, a scientist at the Institut National de la Santé et de la Recherche Médical (INSERM) Unité 550 at Necker Medical School, Paris, and co-author of the study.

Dr. Erwin Schurr is a Scientist at the McGill Centre for the Study of Host Resistance, a Researcher at the McGill University Health Centre, and an Investigator of the Canadian Genetic Diseases Network. Dr. Thomas Hudson is Director of the Genome Quebec Innovation Centre, a Scientist at the McGill University Health Centre, and an Investigator of the Canadian Genetic Diseases Network. The research was supported with grants from the Canadian Genetic Diseases Network, Canadian Institutes of Health Research, and Genome Quebec.

The Canadian Genetic Diseases Network is a not-for-profit corporation, committed to advancing Canada’s scientific and commercial competitiveness in genetic research, and the application of genetic discoveries to prevent, diagnose, and treat human disease. To achieve its objectives, CGDN participates in three essential activities: facilitates and funds collaborative research in human genetics across Canada; educates emerging scientists to excel in human genetic disease research; and facilitates partnerships between industry and academia to translate research discoveries into innovative therapies or diagnostic tests. CGDN is part of the Canadian Network Centres of Excellence program.

For Information contact:
Canadian Genetic Diseases Network:
Dean Sas, Corporate Development and Communications Manager
TEL: 604-221-7300 ext. 110
dsas@cgdn.ca

MUHC Communications Services:
Christine Zeindler
Communications Coordinator (Research)
514-934-1934 ext. 36419
pager: 514-406-1577


Christine Zeindler | EurekAlert!
Further information:
http://www.mcgill.ca/

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>